Blood Plasma Derivatives Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL BLOOD PLASMA DERIVATIVES INDUSTRY

2.1 Summary about Blood Plasma Derivatives Industry

2.2 Blood Plasma Derivatives Market Trends

2.2.1 Blood Plasma Derivatives Production & Consumption Trends

2.2.2 Blood Plasma Derivatives Demand Structure Trends

2.3 Blood Plasma Derivatives Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Fresh Frozen Plasma (FFP) 

4.2.2 Intravenous immunoglobulin (IVIG) 

4.2.3 Albumin 

4.2.4 Factor VIII 

4.2.5 Factor IX

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hemophilia A 

4.3.2 Hemophilia B 

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Fresh Frozen Plasma (FFP) 

5.2.2 Intravenous immunoglobulin (IVIG) 

5.2.3 Albumin 

5.2.4 Factor VIII 

5.2.5 Factor IX

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hemophilia A 

5.3.2 Hemophilia B 

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Fresh Frozen Plasma (FFP) 

6.2.2 Intravenous immunoglobulin (IVIG) 

6.2.3 Albumin 

6.2.4 Factor VIII 

6.2.5 Factor IX

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hemophilia A 

6.3.2 Hemophilia B 

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Fresh Frozen Plasma (FFP) 

7.2.2 Intravenous immunoglobulin (IVIG) 

7.2.3 Albumin 

7.2.4 Factor VIII 

7.2.5 Factor IX

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hemophilia A 

7.3.2 Hemophilia B 

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Fresh Frozen Plasma (FFP) 

8.2.2 Intravenous immunoglobulin (IVIG) 

8.2.3 Albumin 

8.2.4 Factor VIII 

8.2.5 Factor IX

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hemophilia A 

8.3.2 Hemophilia B 

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Fresh Frozen Plasma (FFP) 

9.2.2 Intravenous immunoglobulin (IVIG) 

9.2.3 Albumin 

9.2.4 Factor VIII 

9.2.5 Factor IX

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hemophilia A 

9.3.2 Hemophilia B 

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 SK Plasma (Korea) 

10.1.2 Seraplex Inc. 

10.1.3 Grifols (Germany) 

10.1.4 CSL Limited (Australia) 

10.1.5 Fusion Healthcare (India)

10.2 Blood Plasma Derivatives Sales Date of Major Players (2017-2020e)

10.2.1 SK Plasma (Korea) 

10.2.2 Seraplex Inc. 

10.2.3 Grifols (Germany) 

10.2.4 CSL Limited (Australia) 

10.2.5 Fusion Healthcare (India)

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Blood Plasma Derivatives Product Type Overview

Table Blood Plasma Derivatives Product Type Market Share List

Table Blood Plasma Derivatives Product Type of Major Players

Table Brief Introduction of SK Plasma (Korea) 

Table Brief Introduction of Seraplex Inc. 

Table Brief Introduction of Grifols (Germany) 

Table Brief Introduction of CSL Limited (Australia) 

Table Brief Introduction of Fusion Healthcare (India)

Table Products & Services of SK Plasma (Korea) 

Table Products & Services of Seraplex Inc. 

Table Products & Services of Grifols (Germany) 

Table Products & Services of CSL Limited (Australia) 

Table Products & Services of Fusion Healthcare (India)

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Blood Plasma Derivatives Market Forecast (Million USD) by Region 2021f-2026f

Table Global Blood Plasma Derivatives Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Blood Plasma Derivatives Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Blood Plasma Derivatives Market Forecast (Million USD) Share by Demand 2021f-2026f